Proteins with intrinsically disordered regions (IDRs) are of intense interest, as they are broadly toxic in diverse organisms when their expression is elevated (
Vavouri et al., 2009) and feature in many protein misfolding diseases (
Stefani and Dobson, 2003). Intrinsically disordered proteins often form amyloids, β sheet–rich fibrous structures (
Chiti and Dobson, 2006). Amyloid formation is associated with many human diseases (
Ross and Poirier, 2005), yet it is no longer thought to be the primary source of toxicity in most of these diseases (
Kayed et al., 2003;
Treusch et al., 2009). Rather, it is the propensity of intrinsically disordered forms of amyloidogenic proteins to accumulate as soluble oligomers and amorphous aggregates that enables their gain-of-function toxicities.
The complex biology of proteins with IDRs has made the nature of their toxicities difficult to decipher. Their common gene dosage–related toxicity likely arises from detrimental, mass action–driven promiscuous protein–protein interactions (
Vavouri et al., 2009). The toxicity of artificial β sheet proteins, for example, seems to result from their interactions with disordered proteins that occupy essential hub positions in cellular protein networks (
Olzscha et al., 2011). However, how a simple change in the expression of one protein with a naturally occurring IDR might lead to toxicity is poorly understood at the molecular level.
Yeast prions provide an ideal system for investigating this problem. Yeast prions encompass diverse proteins, unrelated except for the presence of IDRs that can stably exist in two states: a soluble relatively unstructured species or a self-perpetuating amyloid (
Shorter and Lindquist, 2005). These conformational switches can alter the function of associated globular domains, changing the cellular phenotype. The self-templating properties and meiotic transmission of prion assemblies allow them to serve as cytoplasmically inherited protein-based genetic elements (
Tuite and Cox, 2003;
Chien et al., 2004;
Shorter and Lindquist, 2005;
Halfmann and Lindquist, 2010). Seven yeast prions have been well characterized (
Wickner, 1994;
Sondheimer and Lindquist, 2000;
Du et al., 2008;
Alberti et al., 2009;
Brown and Lindquist, 2009;
Patel et al., 2009), and ~20 other yeast proteins contain similar IDRs, prion domains, capable of forming prions (
Alberti et al., 2009).
Rnq1 contains such a prion domain (
Sondheimer and Lindquist, 2000). The only known biological function of Rnq1 is that its prion amyloid state, [
RNQ+], facilitates the transition of other prion proteins from their soluble to their amyloid states (
Derkatch et al., 2000,
2001;
Osherovich and Weissman, 2001;
Taneja et al., 2007). (Prions are denoted by brackets, italics, and capital letters to reflect their dominant, non-Mendelian genetic properties.) [
RNQ+] also affects the conformations of other IDR-containing proteins, exemplified by its ability to induce the glutamine-expanded exon 1 fragment of the human huntingtin protein to adopt a toxic conformation (
Meriin et al., 2002).
In yeast, misfolded proteins accumulate at two distinct sites, the juxtanuclear quality control compartment (JUNQ) and the insoluble protein deposit (IPOD;
Kaganovich et al., 2008). The JUNQ contains polyubiquitinated proteins targeted for proteasomal degradation. The IPOD colocalizes with the preautophagosomal structure at the vacuole and holds amyloidogenic proteins (
Kaganovich et al., 2008;
Tyedmers et al., 2010). [
RNQ+] appears to influence the aggregation of other proteins through its localization to the IPOD (
Kaganovich et al., 2008;
Tyedmers et al., 2010). Both the JUNQ and the IPOD share features with aggresomes—highly structured protein deposits in higher eukaryotes that are actively formed near centrosomes (
Johnston et al., 1998). But neither the JUNQ nor the IPOD associates with the spindle pole body (SPB;
Kaganovich et al., 2008), and the relationship between them and aggresomes remains to be determined (
Mathur et al., 2010).
Overexpression of Rnq1 is completely benign in cells whose endogenous Rnq1 is in the soluble state. But, it is specifically and extremely toxic to cells in which the endogenous Rnq1 protein has adopted the [
RNQ+] prion amyloid state (
Douglas et al., 2008). Notably, it is not excessive amyloid formation that causes toxicity. Rather, Rnq1 amyloid formation is protective. Elevated expression of Sis1, the Hsp40 cochaperone required for Rnq1 amyloid formation (
Sondheimer et al., 2001), enhances amyloid formation and concomitantly restores cell growth. Moreover, Rnq1 point mutations that decrease Sis1 interaction both increase toxicity and the formation of nonamyloid aggregates (
Douglas et al., 2008). As for other proteins with IDRs, how these amorphous nonamyloid aggregates cause toxicity is unknown.
Deletion of
RNQ1 has no detectable effect on cell growth (
Strawn and True, 2006). The fact that loss-of-function phenotypes are not a concern makes Rnq1 a facile model for studying the gain-of-function proteotoxicity caused by the aggregation of proteins with IDRs. Here, we investigate the molecular mechanism by which Rnq1 overexpression results in toxicity. Surprisingly, we find that elevated levels of Rnq1 cause cell cycle arrest through the highly specific sequestration of a component of the SPB.